These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 10652419)

  • 41. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment.
    Di Lonardo A; Marcante ML; Poggiali F; Venuti A
    J Med Virol; 1998 Mar; 54(3):192-5. PubMed ID: 9515768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
    Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
    Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
    Bontkes HJ; de Gruijl TD; van den Muysenberg AJ; Verheijen RH; Stukart MJ; Meijer CJ; Scheper RJ; Stacey SN; Duggan-Keen MF; Stern PL; Man S; Borysiewicz LK; Walboomers JM
    Int J Cancer; 2000 Oct; 88(1):92-8. PubMed ID: 10962445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.
    Sehr P; Zumbach K; Pawlita M
    J Immunol Methods; 2001 Jul; 253(1-2):153-62. PubMed ID: 11384677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of metastasis suppressor gene KAI1 in cervical carcinoma and infections of HPV16 E6, E7 and HPV18 E6/E7].
    Ouyang YW; Pan XL; Peng ZL; Qu Y; Zhang HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):410-3. PubMed ID: 18575327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
    Chee YH; Namkoong SE; Kim DH; Kim SJ; Park JS
    Gynecol Oncol; 1995 May; 57(2):226-31. PubMed ID: 7729739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
    Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
    Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.
    Ramezani A; Aghakhani A; Soleymani S; Bavand A; Bolhassani A
    BMC Infect Dis; 2019 Feb; 19(1):142. PubMed ID: 30755156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.
    Santin AD; Bellone S; Palmieri M; Zanolini A; Ravaggi A; Siegel ER; Roman JJ; Pecorelli S; Cannon MJ
    J Virol; 2008 Feb; 82(4):1968-79. PubMed ID: 18057249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations.
    Nindl I; Zumbach K; Pawlita M; Teller K; Schneider A; Dürst M
    J Infect Dis; 2000 May; 181(5):1764-7. PubMed ID: 10783118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
    Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
    Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
    J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
    Dong D; Zhu Y; Aili Z; Chen Z; Ding J
    Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
    Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
    Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.